FDA Mulls EFPIA Proposal on Enhanced Inspections
This article was originally published in The Tan Sheet
The European pharmaceutical industry has caught FDA’s attention with a sweeping proposal for eventually putting the world’s inspectorates on the same page and simplifying regulatory compliance challenges for global manufacturers.
You may also be interested in...
Singapore recalls trigger international reaction as metformin is added to growing list of chronic medications found to contain NDMA.
Draft recommendation offers path to ICH Q12 regulatory relief.
Accelerating post-approval change oversight by focusing on ‘established conditions’ means trusting pharmaceutical quality management systems. But how?